Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease
One of the most common viruses in the world today is the hepatitis C virus (HCV). It is a virus with a wide range of characteristics, and it reproduces and evolves quickly. The nonstructural proteins (NS3/4a), are responsible for swift multiplication that causes genome variability. Voxilaprevir is a...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-07-01
|
| Series: | Scientific African |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227623000492 |
| _version_ | 1797802183279771648 |
|---|---|
| author | Stephen Ejeh Adamu Uzairu Gideon Adamu Shallangwa Stephen Eyije Abechi Muhammad Tukur Ibrahim Ramith Ramu Mohammed Al-Ghorbani |
| author_facet | Stephen Ejeh Adamu Uzairu Gideon Adamu Shallangwa Stephen Eyije Abechi Muhammad Tukur Ibrahim Ramith Ramu Mohammed Al-Ghorbani |
| author_sort | Stephen Ejeh |
| collection | DOAJ |
| description | One of the most common viruses in the world today is the hepatitis C virus (HCV). It is a virus with a wide range of characteristics, and it reproduces and evolves quickly. The nonstructural proteins (NS3/4a), are responsible for swift multiplication that causes genome variability. Voxilaprevir is a standard drug for the cure of HCV but unfortunately, it receives a lot of attention for its pricing problems. As a result, it is crucial to consider alternative HCV treatments that are both cost-effective and free of side effects. An in-silicon methodology was applied in the current research to virtually search the PubChem database for compounds that are effective against HCV NS3/4a. Molecule 45 (PubChem68792528) was selected based on its lowest binding energy of -44.55 kcal/mol in contrast to the Voxilaprevir with a binding energy of -40.68 kcal/mol. Also Using Voxilaprevir as a guide, the results of MD simulation showed potentially viable lead compounds that could be built into conventional drugs having a high binding energy of -113.724 kj/mol, stable complex, and mechanisms different from the reference compound with a binding energy of -108.132 kj/mol. For the first 10 ns, compound 45′s average RMSD value increased to 0.28 nm, and it stayed there for the remaining 100 ns of the trajectory, fluctuating between 0.26 and 0.28 nm. Comparing these values to the RMSD values of the reference complex over the course of the simulation, compound 45′s structural modeling is shown to be more stable. |
| first_indexed | 2024-03-13T05:01:52Z |
| format | Article |
| id | doaj.art-8eb35e4c27134d92846a73ac270422cd |
| institution | Directory Open Access Journal |
| issn | 2468-2276 |
| language | English |
| last_indexed | 2024-03-13T05:01:52Z |
| publishDate | 2023-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Scientific African |
| spelling | doaj.art-8eb35e4c27134d92846a73ac270422cd2023-06-17T05:19:38ZengElsevierScientific African2468-22762023-07-0120e01591Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a proteaseStephen Ejeh0Adamu Uzairu1Gideon Adamu Shallangwa2Stephen Eyije Abechi3Muhammad Tukur Ibrahim4Ramith Ramu5Mohammed Al-Ghorbani6Physical Chemistry Research Group, Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria Kaduna, Nigeria; Corresponding author.Physical Chemistry Research Group, Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria Kaduna, NigeriaPhysical Chemistry Research Group, Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria Kaduna, NigeriaPhysical Chemistry Research Group, Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria Kaduna, NigeriaPhysical Chemistry Research Group, Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria Kaduna, NigeriaDepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysore, 570015, Karnataka, IndiaDepartment of Chemistry, College of Science and arts, Ulla, Taibah University, Madina 41477, Saudi Arabia; Department of Chemistry, College of Education, Thamar University, Thamar 425897, YemenOne of the most common viruses in the world today is the hepatitis C virus (HCV). It is a virus with a wide range of characteristics, and it reproduces and evolves quickly. The nonstructural proteins (NS3/4a), are responsible for swift multiplication that causes genome variability. Voxilaprevir is a standard drug for the cure of HCV but unfortunately, it receives a lot of attention for its pricing problems. As a result, it is crucial to consider alternative HCV treatments that are both cost-effective and free of side effects. An in-silicon methodology was applied in the current research to virtually search the PubChem database for compounds that are effective against HCV NS3/4a. Molecule 45 (PubChem68792528) was selected based on its lowest binding energy of -44.55 kcal/mol in contrast to the Voxilaprevir with a binding energy of -40.68 kcal/mol. Also Using Voxilaprevir as a guide, the results of MD simulation showed potentially viable lead compounds that could be built into conventional drugs having a high binding energy of -113.724 kj/mol, stable complex, and mechanisms different from the reference compound with a binding energy of -108.132 kj/mol. For the first 10 ns, compound 45′s average RMSD value increased to 0.28 nm, and it stayed there for the remaining 100 ns of the trajectory, fluctuating between 0.26 and 0.28 nm. Comparing these values to the RMSD values of the reference complex over the course of the simulation, compound 45′s structural modeling is shown to be more stable.http://www.sciencedirect.com/science/article/pii/S2468227623000492Virtual screeningMolecular dockingHCV NS3/4aMolecular dynamics simulationBinding energy |
| spellingShingle | Stephen Ejeh Adamu Uzairu Gideon Adamu Shallangwa Stephen Eyije Abechi Muhammad Tukur Ibrahim Ramith Ramu Mohammed Al-Ghorbani Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease Scientific African Virtual screening Molecular docking HCV NS3/4a Molecular dynamics simulation Binding energy |
| title | Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease |
| title_full | Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease |
| title_fullStr | Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease |
| title_full_unstemmed | Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease |
| title_short | Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease |
| title_sort | chemical bioinformatics study of nonadec 7 ene 4 carboxylic acid derivatives via molecular docking and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus ns3 4a protease |
| topic | Virtual screening Molecular docking HCV NS3/4a Molecular dynamics simulation Binding energy |
| url | http://www.sciencedirect.com/science/article/pii/S2468227623000492 |
| work_keys_str_mv | AT stephenejeh chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT adamuuzairu chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT gideonadamushallangwa chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT stepheneyijeabechi chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT muhammadtukuribrahim chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT ramithramu chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease AT mohammedalghorbani chemicalbioinformaticsstudyofnonadec7ene4carboxylicacidderivativesviamoleculardockingandmoleculardynamicsimulationstoidentifynovelleadinhibitorsofhepatitiscvirusns34aprotease |